Status:
COMPLETED
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Appendicitis
Cholecystitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a study of the safety and efficacy of tigecycline to ceftriaxone sodium plus metronidazole in hospitalized subjects with cIAI. Subjects will be followed for efficacy through the test-of-cure a...
Eligibility Criteria
Inclusion
- Clinical diagnosis of complicated intra-abdominal infection that requires surgery within 24 hours.
- Fever plus other symptoms such as nausea, vomiting, abdominal pain.
Exclusion
- Cancer
- Medicines that suppress the immune system
- Dialysis
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
473 Patients enrolled
Trial Details
Trial ID
NCT00230971
Start Date
October 1 2005
End Date
September 1 2008
Last Update
February 25 2013
Active Locations (68)
Enter a location and click search to find clinical trials sorted by distance.
1
Nambour, Queensland, Australia, 4560
2
Cairns, Australia, QLD 4870
3
Parkville, Australia, VIC 3050
4
Shanghai, China, 200032